论文部分内容阅读
目的观察重组人干扰素a-2b治疗病毒疹的临床疗效。方法将116例病毒疹患者随机分为治疗组65例和对照51例。治疗组给予安达芬300万U,每日1次肌注,共4天。对照组给予病毒唑10mg/kg·d每日静输1次,共4天。结果安达芬组治疗病毒疹疗效显著,明显优于对照组。
Objective To observe the clinical efficacy of recombinant human interferon a-2b in the treatment of viral rash. Methods A total of 116 patients with viral rash were randomly divided into treatment group (65 cases) and control group (51 cases). The treatment group was given 3 million U of anandfen intramuscularly once daily for 4 days. The control group was given ribavirin 10mg / kg · d daily intravenous infusion of 1, a total of 4 days. Results Andalfen group treatment of viral rash significant effect, significantly better than the control group.